MAP1LC3A and leukemia: Benfotiamine-treated leukemia cells did not show signs of autophagy as demonstrated by the absence of LC3 protein, a marker of autophagy [19], in cellular extracts from benfotiamine-treated HL-60 cells (S3 Fig).